Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
OrtopediaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- BMJ (Clinical research ed.)
- Publicado em
- 2 mai 2023
- Citações
- 232
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
Mina N Händel, Isabel Cardoso, Cecilie von Bülow, Jeanett Friis Rohde, Anja Ussing, Sabrina Mai Nielsen, Robin Christensen, Jean-Jacques Body, Maria Luisa Brandi, Adolfo Diez-Perez et al.
Descritores MeSH
- Osteoporosis, Postmenopausal
- Osteoporosis
- Spinal Fractures
- Bone Density Conservation Agents
- Osteoporotic Fractures
- Postmenopause
- Risk Reduction Behavior
- Receptor, Parathyroid Hormone, Type 1
- Randomized Controlled Trials as Topic
- Diphosphonates